Epcoritamab-CAR T Cells for Large B-cell Lymphomas

Summary

This study investigates the feasibility and efficacy of epcoritamab treatment before CAR T cells. This study also investigates if, when patients have residual lymphoma after CAR T cells, epcoritamab can help to effectively treat that lymphoma.

Timeline

Start

2024-09-24

Primary completion

2027-10

Completion

2027-12

Drugs

Indications